Bpo
NDC Package 42192-105-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Bpo is a medication used to treat mild to moderate acne. Marketed by Acella Pharmaceuticals, Llc, this product is identified by NDC 42192-105 and is authorized under FDA application M.

Identification & Billing

NDC Package Code
42192-105-16
Package Description
12 CARTON in 1 PACKAGE / 1 TUBE in 1 CARTON / 42500 mg in 1 TUBE
Product Code
11-Digit Billing Format
42192010516

Clinical Specifications

Proprietary Name
Bpo
Dosage Form
-
Usage Information
This medication is used to treat mild to moderate acne. It may be used in combination with other acne treatments. When applied to the skin, benzoyl peroxide works by reducing the amount of acne-causing bacteria and by causing the skin to dry and peel. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.

Regulatory & Marketing

Labeler Name
Acella Pharmaceuticals, Llc
FDA Application #
M
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-01-2009
End Marketing Date
09-11-2018
Listing Expiration
09-11-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (42192-105). Click a package code to view its specific billing and regulatory data.

1 TUBE in 1 PACKAGE / 42500 mg in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42192-105-16 identifies a specific commercial package of 12 carton in 1 package / 1 tube in 1 carton / 42500 mg in 1 tube of Bpo, labeled by Acella Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Acella Pharmaceuticals, Llc on January 01, 2009. The current certification is valid through September 11, 2018.

What are the primary indications for this medication?

This medication is used to treat mild to moderate acne. It may be used in combination with other acne treatments. When applied to the skin, benzoyl peroxide works by reducing the amount of acne-causing bacteria and by causing the skin to dry and peel. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.

How is this Acella Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42192010516. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42192-105-16
11-Digit CMS (5-4-2)
42192-0105-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.